Square Halts Hemp and CBD Sales Amid Anticipated Federal Regulatory Changes

Square, a major point-of-sale platform, has notified merchants that it will no longer permit the sale of CBD and hemp-derived products due to anticipated changes in federal legislation. The payment processor cited legal concerns regarding products that may face recriminalization under forthcoming federal rules. This decision affects numerous small businesses and retailers who depend on these platforms to sell wellness products. The move reflects growing uncertainty in the hemp and CBD industry as federal policy continues to evolve, potentially impacting consumer access to products used for various health conditions.

Originally published on
Marijuana Moment
By Tom Angell
Read full article(opens in new tab)Fetched: August 8, 2026 at 10:05 AM

